World of DTC Marketing

DECEMBER 18, 2020

Pharma companies are still too focused on profits while people continue to rely on prescription drugs to compensate for unhealthy lifestyles. The headline and byline in a Times editorial said it all “Don’t Fall for Big Pharma’s Savior Act, Heroic work went into the development of the coronavirus vaccines.

Generic Drugs 155

Generic Drugs Drugs Pharma Companies Vaccine 155

Creogenic Pharma

APRIL 15, 2023

The Indian pharmaceutical market reached a value of around $27 billion by the end of 2017 and is predicted to experience a CAGR of over 5% for the next five years, reaching over $60 billion by 2022. India is a major player in the global pharmaceutical industry, accounting for almost 20% of the export volume of generic drugs worldwide.

Pharma Companies 40

Pharma Companies Production Manufacturing Generic Drugs 40

pharmaphorum

AUGUST 20, 2020

.” This is the latest in a string of legal troubles for the Israel-based pharma in the US, where it already faces lawsuits that it improperly marketed an opioid painkiller, and colluded with other pharma companies to fix the price of generic drugs.

Generic Drugs 115

Generic Drugs Sales Pharmacy Pharma Companies 115

Pharmaceutical Technology

SEPTEMBER 23, 2022

For pharma and biotech companies, there are many advantages to partnering with a Contract Development and Manufacturing Organisations (CDMO): they can access more specialized knowledge, state-of-the-art equipment, and qualified staff, as well as reduce their total cost of ownership, all while maintaining speed to market.

Manufacturing 147

Manufacturing Drugs Production Development 147

pharmaphorum

JUNE 8, 2021

Dr Jay Mei from Antengene tells us how the Asia Pacific region is opening up to innovative pharma companies, and gives tips for companies navigating this enormous market. At the same time, lots of people with experience at multinational pharmaceutical companies have chosen to return home.

Marketing 105

Marketing Drugs Development Regulation 105

pharmaphorum

SEPTEMBER 9, 2022

Pharma companies are “highly vulnerable” to the effects of climate change, due to their reliance on global networks. To meet the growing demand and market opportunity, a pharma company must ensure it has the resources, capacity, and supply chain to grow.”. Vulnerability . Making plans is not enough.

Production 105

Production Pharma Companies Generic Drugs Medicine 105

pharmaphorum

JULY 28, 2022

Logistical challenges of getting the right materials in the right place remain two years after the pandemic began, causing significant drug shortages to end-users. Many of the medicines most badly affected by these shortages are generic drugs to treat common conditions such as diabetes and heart disease.

Compliance 111

Compliance Drugs Manufacturing Generic Drugs 111

Pharmaceutical Technology

JULY 15, 2022

Nothing epitomises market failures more than the cost of insulin,” Newsom said in a video posted on Twitter. CivicaRx is a non-profit generic drug company producing affordable insulin biosimilars in collaboration with the Juvenile Diabetes Research Foundation (JDRF). In-house manufacturing the norm.

Insulin 328

Insulin Manufacturing Contract Manufacturing Production 328

Pharmaceutical Technology

DECEMBER 15, 2022

Inflation at its current levels poses a major threat to generics production and usage. Since the summer, generics makers have been signalling that additional support for help with rising costs is required to keep generics production viable. Inflation can damage production viability of European drugs.

Medicine 246

Medicine Manufacturing Pharma Companies Production 246

Pharmaceutical Commerce

FEBRUARY 6, 2025

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, James Shehan, chair of the FDA Regulatory practice at Lowenstein Sandler, describes what the approach of pharma companies should be amid the latest/pending tariffs imposed on Canada, Mexico, and China, along with their potential impact on the pharma supply chain. (..)

Generic Drugs 59

Generic Drugs Pharma Companies Marketing Drugs 59

Pharmaceutical Technology

AUGUST 12, 2022

In principle, the deal could create new opportunities for British pharma companies – not least the chance to work under a more supportive regulatory framework. Among the negative effects that have been reported are supply chain disruptions, skills shortages, issues around market authorisation, and added costs for pharma CMOs.

Medicine 290

Medicine Production Generic Drugs Regulation 290

pharmaphorum

MARCH 5, 2021

The European Commission has formally opened an antitrust investigation into Teva, which will assess whether the pharma company illegally delayed launches and use of generic versions of its blockbuster multiple sclerosis drug Copaxone.

Drugs 98

Drugs Sales Pharma Companies Generic Drugs 98

Pharma Marketing Network

NOVEMBER 24, 2024

But how do you stand out in a crowded market? Let’s explore the top strategies pharma marketers can adopt to thrive. Understanding the Pharma Market Landscape To succeed, you need to understand the shifting dynamics of healthcare marketing. What resonates with them? Empathy and transparency.

Sales 52

Sales Marketing Compliance Branding 52

Pharma Marketing Network

FEBRUARY 27, 2025

Introduction In todays fast-paced world, pharma digital marketing is more than just a strategyit’s a necessity. But how can pharma marketers break through the noise, engage their audience, and see real ROI? Think of digital marketing as the GPS guiding your brand through a crowded, competitive landscape.

Branding 52

Branding Marketing Compliance Regulation 52

Pharma Marketing Network

MARCH 12, 2025

Pharmaceutical marketers face a unique challenge. Unlike consumer brands that can use aggressive bidding strategies on high-volume keywords, pharma ads must navigate strict regulatory guidelines. For an in-depth look at how pharma companies succeed in digital advertising, visit Pharma Marketing Network.

Marketing 59

Marketing Research Compliance Branding 59

Pharmaceutical Technology

MARCH 22, 2023

During the pandemic, the shortage of basic drugs such as paracetamol in key EU countries led to growing calls to push local drug manufacturing to ensure a smooth supply and to minimise shortages. Despite having large biopharmaceutical companies on home ground, the UK and France experienced major shortages and supply chain issues.

Production 263

Production Manufacturing Drugs Generic Drugs 263